Preventing Intravenous Immunoglobulin-associated Adverse Reactions

Clinical trial NCT00675805 · COMPLETED

Trial details

NCT number: NCT00675805
Sponsor: University Hospital, Basel, Switzerland
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Immunoglobulin Therapy

Start date: 2008-05-01
Primary completion: 2012-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.